Novo Nordisk Other Share Holders Equity 2012-2026 | NVO

Novo Nordisk other share holders equity for the quarter ending March 31, 2026 was $-0.595B, a 642.64% decline year-over-year.

  • Novo Nordisk other share holders equity for 2025 was $-0.257B, a 25.88% increase from 2024.
  • Novo Nordisk other share holders equity for 2024 was $-0.204B, a 210.04% decline from 2023.
  • Novo Nordisk other share holders equity for 2023 was $0.185B, a 46.57% decline from 2022.

Novo Nordisk Other Share Holders Equity 2012-2026 | NVO

  • Novo Nordisk other share holders equity for 2025 was $-0.257B, a 25.88% increase from 2024.
  • Novo Nordisk other share holders equity for 2024 was $-0.204B, a 210.04% decline from 2023.
  • Novo Nordisk other share holders equity for 2023 was $0.185B, a 46.57% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B